Here’s the FDA’s Final Guidance on Cannabis and Clinical Research 

The FDA’s long-awaited guidance for non-medical products containing CBD, which are already widely available despite being unregulated, is still in the works.

Congress, Hemp

House Ag Committee Votes to “Close the Loophole” on Intoxicating Hemp During Farm Bill Markup 

Committee members who opposed the amendment argued that a ban on hemp-derived products would lead to job loss.


NY Senators use Dormitory Authority hearing to seek answers on troubled equity fund • & more …

An excerpt from recent editions of the Cannabis Wire Daily newsletter.